Clinical Trials Directory

Trials / Completed

CompletedNCT00782912

Postpartum Anemia and Postpartum Depression

Is Postpartum Anemia an Independent Risk Factor for Development of Postpartum Depression?

Status
Completed
Phase
Study type
Observational
Enrollment
103 (actual)
Sponsor
Unity Health Toronto · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Postpartum anemia (PPA) and Postpartum depression (PPD) are common afflictions affecting women after childbirth. Both disorders have a significant impact on women's health and functional status. Despite common symptoms and characteristics, a link between these entities has not been adequately studied. The objective of this study is to determine whether postpartum anemia is an independent risk factor for the development of postpartum depression. This prospective cohort study will include all women delivered by elective term cesarean delivery. Hemoglobin and iron levels will be measured, standardized questionnaires for assessment of PPD, functional status and lactation will be administered before discharge and at 3 \& 6 weeks post partum. Hemoglobin levels at each time point will be analyzed for correlation with depressive symptoms, functional status and lactation success.

Conditions

Timeline

Start date
2008-11-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2008-10-31
Last updated
2019-02-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00782912. Inclusion in this directory is not an endorsement.

Postpartum Anemia and Postpartum Depression (NCT00782912) · Clinical Trials Directory